Emmanuelle Comets
Inserm · 180 works · 4,002 citations · h-index 31
Top works
- Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide
- Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
- Are Population Pharmacokinetic and/or Pharmacodynamic Models Adequately Evaluated?
- Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
- Association of an IRF5 gene functional polymorphism with Sjögren's syndrome
- Model evaluation in nonlinear mixed effect models, with applications to pharmacokinetics
- Parameter Estimation in Nonlinear Mixed Effect Models Using saemix, an R Implementation of the SAEM Algorithm
- Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients
- Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey
- New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale
- Evaluation of different tests based on observations for external model evaluation of population analyses
- The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome
- Design in nonlinear mixed effects models: Optimization using the Fedorov–Wynn algorithm and power of the Wald test for binary covariates
- A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed‐effects models
- Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics
- Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients*
- STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling
- Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice
- A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis